[摘要] 目的 观察眼底激光联合雷珠单抗治疗糖尿病视网膜病变的临床效果。 方法 选择2017年3月—2018年3月该院收治的糖尿病视网膜病变患者54例，按照随机数字表法分为两组。所有患者均先行玻璃体腔注药治疗，1周后再进行眼底激光治疗。在玻璃体腔注药时，观察组27例(33眼)患者采用雷珠单抗，对照组27例患者(31眼)采用曲安奈德。 结果 术后3个月观察组黄斑区视网膜厚度低于对照组(P<0.05)。两组视力改善比较差异无统计学意义(P>0.05)。观察组眼底出血消失时间、渗出消失时间、视网膜水肿消失时间短于对照组(P<0.05)。 结论 眼底激光联合雷珠单抗治疗糖尿病视网膜病变可加速术后恢复。

    [关键词] 糖尿病视网膜病变;雷珠单抗;激光

    [中图分类号] R774.1 [文献标识码] A [文章编号] 1672-4062(2019)08(a)-0180-02

    [Abstract] Objective To observe the clinical effect of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy. Methods A total of 54 patients with diabetic retinopathy admitted to our hospital from March 2017 to March 2018 were enrolled and divided into 2 groups according to the random number table method. All patients were treated with vitreous cavity injection ......